课题基金基金详情
基于USP10/BASP1/HOXB9通路的鸦胆子苦醇干预黑色素瘤细胞干性的机制研究
结题报告
批准号:
81973603
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
林景荣
依托单位:
学科分类:
中西医结合临床基础
结题年份:
2023
批准年份:
2019
项目状态:
已结题
项目参与者:
林景荣
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
黑色素瘤是一种病死率高的恶性肿瘤,进展快、易耐药,针对黑色素瘤细胞干性的分子靶向治疗是近年研究热点。黑色素瘤中医属热盛血瘀肉腐之证,寒凉中药鸦胆子有清热去腐、清火攻实之效,可治疗多种肿瘤,但对黑色素瘤的作用机制尚无深入研究。前期研究显示,鸦胆子主要活性成分鸦胆子苦醇可上调USP10及BASP1,后者进一步抑制其靶基因HOXB9表达。课题组已发表成果表明,HOXB9参与黑色素瘤细胞干性的调控。据此我们推测,鸦胆子苦醇通过USP10/BASP1/HOXB9通路抑制黑色素瘤细胞干性。本课题拟通过泛素化实验和免疫共沉淀等检测USP10与BASP1的相互作用,利用荧光素酶报告基因检测等明确BASP1参与HOXB9转录调控,通过动物模型研究鸦胆子苦醇对黑色素瘤在体内的抑制作用,并分析上述分子的临床相关性。从临床、动物、细胞、分子水平,研究鸦胆子苦醇对黑色素瘤的作用机制,充实“清火攻实”的中医理论内涵。
英文摘要
Melanoma is a malignant skin tumor with a high mortality rate and rapid progress. It is prone to drug resistance. Molecular targeted therapy focusing stemness of melanoma stem cells has been hot topic of research in recent years. According to traditional Chinese medical theory, melanoma belongs to the heat predominance-blood stasis-tissue decay syndrome. The herb of cold and cool nature, traditional Chinese medicine brucea javanica has the effects of clearing heat-fire, inhibiting decay and targeting sthenia pathogenic factors. It has been used to treat several kinds of tumors. However, its effects and mechanism in melanoma hasn’t been deeply studied. Our previous data revealed that the main active constituent of brucea javanica, brusatol, could upregulate USP10 and BASP1, and BASP1 could further inhibit the expression of its downstream target gene HOXB9. Our published data suggested that HOXB9 could regulate the stemness of melanoma cells. Thus, we speculate that brusatol might inhibit melanoma cell stemness through the USP10/BASP1/HOXB9 pathway. This project tries to explore the interaction between USP10 and BASP1 through co-immunoprecipitation and ubiquitination assay, confirm the transcriptional regulation of HOXB9 by BASP1 through Luciferase and realtime PCR, elucidate the inhibitory effects of brusatol on melanoma through tumor xenograft mouse model, and analyze the clinical correlation of the above molecules through statistical analysis. We endeavor to study the mechanism of brusatol’s effects on melanoma on the clinical, animal, celluar and molecular levels, and enrich the connotation of “Qing huo gong shi” traditional theory.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4.
ITIH5 是一种 p53 响应基因,通过下调 KLF4 的转录活性来抑制黑色素瘤细胞的生长和转移
DOI:10.1038/s41419-021-03707-7
发表时间:2021-05-02
期刊:Cell death & disease
影响因子:9
作者:Liu J;Cao F;Li X;Zhang L;Liu Z;Li X;Lin J;Han C
通讯作者:Han C
DOI:10.1371/journal.pone.0263311
发表时间:2022
期刊:PloS one
影响因子:3.7
作者:Shi X;Zhou Q;Huang B;Xia S;Jiang Y;Fang S;Lin J
通讯作者:Lin J
DOI:--
发表时间:2023
期刊:Biomed Pharmacother
影响因子:--
作者:Ziming Guo;Na Li;Yuankuan Jiang;Li Zhang;Lidong Tong;Yipin Wang;Peng Lv;Xiaojie Li;Chuanchun Han;Jingrong Lin
通讯作者:Jingrong Lin
恶性黑素瘤增殖、侵袭、转移及衰老过程中BRAF V600E突变的作用的研究
  • 批准号:
    81102070
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    林景荣
  • 依托单位:
国内基金
海外基金